ChemicalBook
English   Japanese   Germany   Korea

Glycine, N-[4-[2-[2-[4-[2-[1-amino-8-hydroxy-7-(2-phenyldiazenyl)-3,6-disulfo-2-naphthalenyl]diazenyl]phenyl]-1H-benzimidazol-6-yl]diazenyl]-3-hydroxyphenyl]-, sodium salt (1:2)

, 135990-85-1, 结构式
CAS号:
135990-85-1
英文名:
Glycine, N-[4-[2-[2-[4-[2-[1-amino-8-hydroxy-7-(2-phenyldiazenyl)-3,6-disulfo-2-naphthalenyl]diazenyl]phenyl]-1H-benzimidazol-6-yl]diazenyl]-3-hydroxyphenyl]-, sodium salt (1:2)
英文别名:
Direct Black 171;C.I.Direct Black 171:C.I.335500;Glycine, N-[4-[2-[2-[4-[2-[1-amino-8-hydroxy-7-(2-phenyldiazenyl)-3,6-disulfo-2-naphthalenyl]diazenyl]phenyl]-1H-benzimidazol-6-yl]diazenyl]-3-hydroxyphenyl]-, sodium salt (1:2)
中文名:
中文别名:
CBNumber:
CB55488864
分子式:
C37H29N10NaO10S2
分子量:
860.81
MOL File:
135990-85-1.mol

Glycine, N-[4-[2-[2-[4-[2-[1-amino-8-hydroxy-7-(2-phenyldiazenyl)-3,6-disulfo-2-naphthalenyl]diazenyl]phenyl]-1H-benzimidazol-6-yl]diazenyl]-3-hydroxyphenyl]-, sodium salt (1:2)化学性质

安全信息

Glycine, N-[4-[2-[2-[4-[2-[1-amino-8-hydroxy-7-(2-phenyldiazenyl)-3,6-disulfo-2-naphthalenyl]diazenyl]phenyl]-1H-benzimidazol-6-yl]diazenyl]-3-hydroxyphenyl]-, sodium salt (1:2)性质、用途与生产工艺

Glycine, N-[4-[2-[2-[4-[2-[1-amino-8-hydroxy-7-(2-phenyldiazenyl)-3,6-disulfo-2-naphthalenyl]diazenyl]phenyl]-1H-benzimidazol-6-yl]diazenyl]-3-hydroxyphenyl]-, sodium salt (1:2) 上下游产品信息

上游原料

下游产品


Glycine, N-[4-[2-[2-[4-[2-[1-amino-8-hydroxy-7-(2-phenyldiazenyl)-3,6-disulfo-2-naphthalenyl]diazenyl]phenyl]-1H-benzimidazol-6-yl]diazenyl]-3-hydroxyphenyl]-, sodium salt (1:2) 生产厂家

 

135990-85-1, Glycine, N-[4-[2-[2-[4-[2-[1-amino-8-hydroxy-7-(2-phenyldiazenyl)-3,6-disulfo-2-naphthalenyl]diazenyl]phenyl]-1H-benzimidazol-6-yl]diazenyl]-3-hydroxyphenyl]-, sodium salt (1:2) 相关搜索:

  • C37H28N10O10S22Na
  • 135990-85-1
  • Direct Black 171
  • C.I.Direct Black 171:C.I.335500
  • Glycine, N-[4-[2-[2-[4-[2-[1-amino-8-hydroxy-7-(2-phenyldiazenyl)-3,6-disulfo-2-naphthalenyl]diazenyl]phenyl]-1H-benzimidazol-6-yl]diazenyl]-3-hydroxyphenyl]-, sodium salt (1:2)
Copyright 2016 © ChemicalBook. All rights reserved